Wednesday, January 9, 2019 Daily Archives

Third Korean plant with 120,000L capacity back on for Celltrion

by

Celltrion has confirmed its third biomanufacturing plant will be constructed in Korea after assessing locations overseas. The facility will have 120,000 L of biologics capacity. Seo Jeong-jin, chairman of Korean drugmaker Celltrion, told investors at last year’s JP Morgan Healthcare Conference that plans laid down in 2016 to build a third biomanufacturing facility at its site in Songdo, Incheon had been scrapped in favor of a much larger facility overseas. But a year on and Celltrion has announced a U-turn.…

January 9, 2019

China’s biotech growth drives Pall center of excellence in Shanghai

by

Pall has established a Center of Excellence in Shanghai, China to service a biotech sector it says is worth $500 million and set to grow by double-digits. Bioprocessing vendor Pall has several centers of excellence (CoE) set up globally to showcase its biomanufacturing offerings and has now opened a center in Shanghai to service the Chinese market. “The goal of the CoE is to facilitate training and adoption of the advanced manufacturing technologies that will improve the productivity and robustness…

January 9, 2019